| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | disaccharide binding | 5.45e-07 | 7 | 51 | 3 | GO:0048030 | |
| GeneOntologyMolecularFunction | galactoside binding | 1.30e-06 | 9 | 51 | 3 | GO:0016936 | |
| GeneOntologyMolecularFunction | oligosaccharide binding | 1.74e-05 | 20 | 51 | 3 | GO:0070492 | |
| GeneOntologyMolecularFunction | hyaluronic acid binding | 5.47e-05 | 29 | 51 | 3 | GO:0005540 | |
| GeneOntologyMolecularFunction | cytokine activity | 4.34e-04 | 250 | 51 | 5 | GO:0005125 | |
| GeneOntologyMolecularFunction | molecular function activator activity | LGALS9C BMP8B METRN ARHGAP23 LGALS9B WNT6 BMP8A IL17D LGALS9 IFNL1 | 9.72e-04 | 1233 | 51 | 10 | GO:0140677 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 1.04e-03 | 78 | 51 | 3 | GO:0043539 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 1.14e-03 | 310 | 51 | 5 | GO:0030246 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell degranulation | 6.03e-08 | 4 | 52 | 3 | GO:0043322 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell degranulation | 8.39e-07 | 8 | 52 | 3 | GO:0043321 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell activation | 6.73e-06 | 15 | 52 | 3 | GO:0032815 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell proliferation | 6.73e-06 | 15 | 52 | 3 | GO:2000562 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte degranulation | 1.00e-05 | 17 | 52 | 3 | GO:0043301 | |
| GeneOntologyBiologicalProcess | natural killer cell degranulation | 1.20e-05 | 18 | 52 | 3 | GO:0043320 | |
| GeneOntologyBiologicalProcess | negative regulation of alpha-beta T cell proliferation | 1.42e-05 | 19 | 52 | 3 | GO:0046642 | |
| GeneOntologyBiologicalProcess | positive regulation of defense response to bacterium | 1.42e-05 | 19 | 52 | 3 | GO:1900426 | |
| GeneOntologyBiologicalProcess | regulation of T cell chemotaxis | 1.67e-05 | 20 | 52 | 3 | GO:0010819 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell differentiation | 1.95e-05 | 21 | 52 | 3 | GO:0032823 | |
| GeneOntologyBiologicalProcess | regulation of defense response to bacterium | 3.77e-05 | 26 | 52 | 3 | GO:1900424 | |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, alpha-beta T cell proliferation | 4.74e-05 | 28 | 52 | 3 | GO:2000561 | |
| GeneOntologyBiologicalProcess | positive regulation of neural precursor cell proliferation | 4.93e-05 | 80 | 52 | 4 | GO:2000179 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell proliferation | 5.85e-05 | 30 | 52 | 3 | GO:0035739 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte chemotaxis | 6.46e-05 | 31 | 52 | 3 | GO:1901623 | |
| GeneOntologyBiologicalProcess | positive regulation of regulatory T cell differentiation | 6.46e-05 | 31 | 52 | 3 | GO:0045591 | |
| GeneOntologyBiologicalProcess | negative regulation of regulated secretory pathway | 7.12e-05 | 32 | 52 | 3 | GO:1903306 | |
| GeneOntologyBiologicalProcess | T cell chemotaxis | 7.82e-05 | 33 | 52 | 3 | GO:0010818 | |
| GeneOntologyBiologicalProcess | cellular response to virus | 7.82e-05 | 90 | 52 | 4 | GO:0098586 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation in thymus | 1.11e-04 | 37 | 52 | 3 | GO:0033081 | |
| GeneOntologyBiologicalProcess | natural killer cell differentiation | 1.20e-04 | 38 | 52 | 3 | GO:0001779 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | 1.40e-04 | 614 | 52 | 8 | GO:0010720 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.40e-04 | 40 | 52 | 3 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell activation | 1.40e-04 | 40 | 52 | 3 | GO:2000515 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell migration | 1.51e-04 | 41 | 52 | 3 | GO:2000406 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 1.51e-04 | 41 | 52 | 3 | GO:0002716 | |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 1.62e-04 | 42 | 52 | 3 | GO:0002323 | |
| GeneOntologyBiologicalProcess | positive regulation of macrophage activation | 1.62e-04 | 42 | 52 | 3 | GO:0043032 | |
| GeneOntologyBiologicalProcess | positive regulation of SMAD protein signal transduction | 1.74e-04 | 43 | 52 | 3 | GO:0060391 | |
| GeneOntologyBiologicalProcess | maintenance of protein location | 1.82e-04 | 112 | 52 | 4 | GO:0045185 | |
| GeneOntologyBiologicalProcess | positive regulation of neuroblast proliferation | 1.86e-04 | 44 | 52 | 3 | GO:0002052 | |
| GeneOntologyBiologicalProcess | negative regulation of exocytosis | 1.99e-04 | 45 | 52 | 3 | GO:0045920 | |
| GeneOntologyBiologicalProcess | positive regulation of oxidoreductase activity | 2.13e-04 | 46 | 52 | 3 | GO:0051353 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 2.27e-04 | 47 | 52 | 3 | GO:0001911 | |
| GeneOntologyBiologicalProcess | regulation of T-helper 17 type immune response | 2.27e-04 | 47 | 52 | 3 | GO:2000316 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-10 production | 2.41e-04 | 48 | 52 | 3 | GO:0032733 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-6 production | 2.53e-04 | 122 | 52 | 4 | GO:0032755 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte migration | 2.57e-04 | 49 | 52 | 3 | GO:2000403 | |
| GeneOntologyBiologicalProcess | regulation of regulatory T cell differentiation | 2.57e-04 | 49 | 52 | 3 | GO:0045589 | |
| GeneOntologyBiologicalProcess | negative regulation of type II interferon production | 2.89e-04 | 51 | 52 | 3 | GO:0032689 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 3.06e-04 | 52 | 52 | 3 | GO:0031342 | |
| GeneOntologyBiologicalProcess | negative regulation of alpha-beta T cell activation | 3.06e-04 | 52 | 52 | 3 | GO:0046636 | |
| GeneOntologyBiologicalProcess | lymphocyte chemotaxis | 3.24e-04 | 53 | 52 | 3 | GO:0048247 | |
| GeneOntologyBiologicalProcess | regulation of alpha-beta T cell proliferation | 3.24e-04 | 53 | 52 | 3 | GO:0046640 | |
| GeneOntologyBiologicalProcess | regulatory T cell differentiation | 3.42e-04 | 54 | 52 | 3 | GO:0045066 | |
| GeneOntologyBiologicalProcess | regulation of cell development | LGALS9C METRN LGALS9B NCAN HAPLN4 HAPLN2 RASSF10 IL17D LGALS9 IFNL1 | 3.51e-04 | 1095 | 52 | 10 | GO:0060284 |
| GeneOntologyBiologicalProcess | regulation of neural precursor cell proliferation | 3.72e-04 | 135 | 52 | 4 | GO:2000177 | |
| GeneOntologyBiologicalProcess | regulation of T cell migration | 3.81e-04 | 56 | 52 | 3 | GO:2000404 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell proliferation | 4.45e-04 | 59 | 52 | 3 | GO:0046633 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell activation | 4.91e-04 | 61 | 52 | 3 | GO:0032814 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte degranulation | 5.39e-04 | 63 | 52 | 3 | GO:0043300 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 5.39e-04 | 63 | 52 | 3 | GO:0007157 | |
| GeneOntologyBiologicalProcess | T-helper 17 type immune response | 5.65e-04 | 64 | 52 | 3 | GO:0072538 | |
| GeneOntologyBiologicalProcess | regulation of type II interferon production | 6.27e-04 | 155 | 52 | 4 | GO:0032649 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 6.43e-04 | 276 | 52 | 5 | GO:0007179 | |
| GeneOntologyBiologicalProcess | regulation of neuroblast proliferation | 6.46e-04 | 67 | 52 | 3 | GO:1902692 | |
| GeneOntologyBiologicalProcess | cornea development in camera-type eye | 7.31e-04 | 16 | 52 | 2 | GO:0061303 | |
| GeneOntologyBiologicalProcess | negative regulation of immune effector process | 8.11e-04 | 166 | 52 | 4 | GO:0002698 | |
| GeneOntologyBiologicalProcess | diet induced thermogenesis | 8.28e-04 | 17 | 52 | 2 | GO:0002024 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 8.57e-04 | 445 | 52 | 6 | GO:0141091 | |
| GeneOntologyBiologicalProcess | regulation of interleukin-10 production | 8.63e-04 | 74 | 52 | 3 | GO:0032653 | |
| GeneOntologyBiologicalProcess | type II interferon production | 8.67e-04 | 169 | 52 | 4 | GO:0032609 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell activation | 9.06e-04 | 171 | 52 | 4 | GO:0050868 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 9.33e-04 | 76 | 52 | 3 | GO:0042269 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte migration | 9.69e-04 | 77 | 52 | 3 | GO:2000401 | |
| GeneOntologyBiologicalProcess | interleukin-10 production | 9.69e-04 | 77 | 52 | 3 | GO:0032613 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell apoptotic process | 1.04e-03 | 19 | 52 | 2 | GO:0070234 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 1.08e-03 | 80 | 52 | 3 | GO:0002715 | |
| GeneOntologyBiologicalProcess | T cell migration | 1.12e-03 | 81 | 52 | 3 | GO:0072678 | |
| GeneOntologyBiologicalProcess | regulation of macrophage activation | 1.12e-03 | 81 | 52 | 3 | GO:0043030 | |
| GeneOntologyBiologicalProcess | receptor clustering | 1.20e-03 | 83 | 52 | 3 | GO:0043113 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 1.20e-03 | 83 | 52 | 3 | GO:0002707 | |
| GeneOntologyBiologicalProcess | positive regulation of chemokine production | 1.25e-03 | 84 | 52 | 3 | GO:0032722 | |
| GeneOntologyBiologicalProcess | regulation of oxidoreductase activity | 1.25e-03 | 84 | 52 | 3 | GO:0051341 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 1.29e-03 | 482 | 52 | 6 | GO:0007178 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte cell-cell adhesion | 1.39e-03 | 192 | 52 | 4 | GO:1903038 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-1 production | 1.43e-03 | 88 | 52 | 3 | GO:0032732 | |
| GeneOntologyBiologicalProcess | regulation of SMAD protein signal transduction | 1.52e-03 | 90 | 52 | 3 | GO:0060390 | |
| GeneOntologyBiologicalProcess | regulation of interleukin-5 production | 1.52e-03 | 23 | 52 | 2 | GO:0032674 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 1.55e-03 | 336 | 52 | 5 | GO:0071560 | |
| GeneOntologyBiologicalProcess | regulation of interleukin-13 production | 1.66e-03 | 24 | 52 | 2 | GO:0032656 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte apoptotic process | 1.66e-03 | 24 | 52 | 2 | GO:0070230 | |
| GeneOntologyBiologicalProcess | interleukin-5 production | 1.66e-03 | 24 | 52 | 2 | GO:0032634 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 1.69e-03 | 343 | 52 | 5 | GO:0071559 | |
| GeneOntologyBiologicalProcess | interleukin-13 production | 1.80e-03 | 25 | 52 | 2 | GO:0032616 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 1.83e-03 | 96 | 52 | 3 | GO:0002704 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 1.94e-03 | 354 | 52 | 5 | GO:0050769 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte activation | 1.96e-03 | 211 | 52 | 4 | GO:0051250 | |
| GeneOntologyBiologicalProcess | regulation of interleukin-6 production | 2.00e-03 | 212 | 52 | 4 | GO:0032675 | |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, alpha-beta T cell activation | 2.06e-03 | 100 | 52 | 3 | GO:2000514 | |
| GeneOntologyBiologicalProcess | negative regulation of secretion by cell | 2.07e-03 | 214 | 52 | 4 | GO:1903531 | |
| GeneOntologyBiologicalProcess | positive regulation of mononuclear cell migration | 2.30e-03 | 104 | 52 | 3 | GO:0071677 | |
| GeneOntologyBiologicalProcess | neuroblast proliferation | 2.30e-03 | 104 | 52 | 3 | GO:0007405 | |
| GeneOntologyBiologicalProcess | interleukin-6 production | 2.32e-03 | 221 | 52 | 4 | GO:0032635 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 2.36e-03 | 105 | 52 | 3 | GO:0042267 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | 2.49e-03 | 107 | 52 | 3 | GO:0042130 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | 2.49e-03 | 375 | 52 | 5 | GO:0007162 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 2.52e-03 | 226 | 52 | 4 | GO:0045580 | |
| GeneOntologyCellularComponent | perineuronal net | 1.53e-06 | 10 | 50 | 3 | GO:0072534 | |
| GeneOntologyCellularComponent | perisynaptic extracellular matrix | 2.10e-06 | 11 | 50 | 3 | GO:0098966 | |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 3.62e-06 | 13 | 50 | 3 | GO:0099535 | |
| GeneOntologyCellularComponent | extracellular matrix | LGALS9C ADAMTS10 LGALS9B WNT6 NCAN HAPLN4 HAPLN2 SSPOP LGALS9 | 2.21e-05 | 656 | 50 | 9 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | LGALS9C ADAMTS10 LGALS9B WNT6 NCAN HAPLN4 HAPLN2 SSPOP LGALS9 | 2.27e-05 | 658 | 50 | 9 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 3.41e-05 | 530 | 50 | 8 | GO:0062023 | |
| MousePheno | enhanced humoral immune response | 1.67e-05 | 17 | 42 | 3 | MP:0020155 | |
| MousePheno | increased T-helper 1 cell number | 2.36e-05 | 19 | 42 | 3 | MP:0008086 | |
| MousePheno | epididymis epithelium degeneration | 2.64e-05 | 3 | 42 | 2 | MP:0004934 | |
| MousePheno | increased spleen germinal center size | 4.28e-05 | 23 | 42 | 3 | MP:0008483 | |
| MousePheno | abnormal lymph node germinal center morphology | 4.28e-05 | 23 | 42 | 3 | MP:0008522 | |
| MousePheno | abnormal T-helper 1 cell number | 4.89e-05 | 24 | 42 | 3 | MP:0008085 | |
| MousePheno | abnormal lymph node secondary follicle morphology | 5.54e-05 | 25 | 42 | 3 | MP:0002346 | |
| MousePheno | lymph node hyperplasia | 1.29e-04 | 33 | 42 | 3 | MP:0008102 | |
| MousePheno | thymus hyperplasia | 1.41e-04 | 34 | 42 | 3 | MP:0000708 | |
| MousePheno | increased susceptibility to induced arthritis | 1.68e-04 | 36 | 42 | 3 | MP:0003724 | |
| MousePheno | epididymis degeneration | 1.83e-04 | 7 | 42 | 2 | MP:0004935 | |
| MousePheno | abnormal lymph node B cell domain morphology | 3.07e-04 | 44 | 42 | 3 | MP:0002344 | |
| MousePheno | abnormal T-helper 1 cell morphology | 3.97e-04 | 48 | 42 | 3 | MP:0002433 | |
| MousePheno | abnormal lymph node cortex morphology | 4.48e-04 | 50 | 42 | 3 | MP:0002343 | |
| MousePheno | increased T-helper cell number | 6.26e-04 | 56 | 42 | 3 | MP:0013763 | |
| MousePheno | decreased regulatory T cell number | 9.25e-04 | 64 | 42 | 3 | MP:0004974 | |
| Domain | LINK | 5.71e-06 | 13 | 52 | 3 | SM00445 | |
| Domain | Link_dom | 5.71e-06 | 13 | 52 | 3 | IPR000538 | |
| Domain | Xlink | 5.71e-06 | 13 | 52 | 3 | PF00193 | |
| Domain | LINK_1 | 5.71e-06 | 13 | 52 | 3 | PS01241 | |
| Domain | LINK_2 | 5.71e-06 | 13 | 52 | 3 | PS50963 | |
| Domain | Gal-bind_lectin | 9.05e-06 | 15 | 52 | 3 | PF00337 | |
| Domain | Gal-bind_lectin | 9.05e-06 | 15 | 52 | 3 | SM00908 | |
| Domain | GALECTIN | 9.05e-06 | 15 | 52 | 3 | PS51304 | |
| Domain | Galectin_CRD | 9.05e-06 | 15 | 52 | 3 | IPR001079 | |
| Domain | GLECT | 9.05e-06 | 15 | 52 | 3 | SM00276 | |
| Domain | Inhibin_asu | 5.82e-04 | 13 | 52 | 2 | IPR002405 | |
| Domain | - | 8.60e-04 | 67 | 52 | 3 | 2.10.90.10 | |
| Domain | Cystine-knot_cytokine | 8.60e-04 | 67 | 52 | 3 | IPR029034 | |
| Domain | - | 2.35e-03 | 95 | 52 | 3 | 2.60.120.200 | |
| Domain | - | 2.50e-03 | 97 | 52 | 3 | 3.10.100.10 | |
| Domain | C-type_lectin-like/link | 2.64e-03 | 99 | 52 | 3 | IPR016186 | |
| Domain | TGFb_propeptide | 2.74e-03 | 28 | 52 | 2 | PF00688 | |
| Domain | TGF-b_N | 2.74e-03 | 28 | 52 | 2 | IPR001111 | |
| Domain | CTDL_fold | 3.30e-03 | 107 | 52 | 3 | IPR016187 | |
| Domain | TGF-beta-rel | 3.57e-03 | 32 | 52 | 2 | IPR015615 | |
| Domain | TGFb_CS | 3.57e-03 | 32 | 52 | 2 | IPR017948 | |
| Domain | TGFB | 4.76e-03 | 37 | 52 | 2 | SM00204 | |
| Domain | TGF-b_C | 4.76e-03 | 37 | 52 | 2 | IPR001839 | |
| Domain | TGF_BETA_2 | 4.76e-03 | 37 | 52 | 2 | PS51362 | |
| Domain | TGF_beta | 4.76e-03 | 37 | 52 | 2 | PF00019 | |
| Domain | TGF_BETA_1 | 4.76e-03 | 37 | 52 | 2 | PS00250 | |
| Domain | TF_fork_head_CS_2 | 7.28e-03 | 46 | 52 | 2 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 7.59e-03 | 47 | 52 | 2 | IPR018122 | |
| Domain | FH | 8.22e-03 | 49 | 52 | 2 | SM00339 | |
| Domain | FORK_HEAD_1 | 8.22e-03 | 49 | 52 | 2 | PS00657 | |
| Domain | FORK_HEAD_2 | 8.22e-03 | 49 | 52 | 2 | PS00658 | |
| Domain | Fork_head_dom | 8.22e-03 | 49 | 52 | 2 | IPR001766 | |
| Domain | FORK_HEAD_3 | 8.22e-03 | 49 | 52 | 2 | PS50039 | |
| Domain | Forkhead | 8.22e-03 | 49 | 52 | 2 | PF00250 | |
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 16990264 | ||
| Pubmed | Galectin-9 Is Critical for Mucosal Adaptive Immunity through the T Helper 17-IgA Axis. | 3.74e-09 | 3 | 55 | 3 | 29458010 | |
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 18005988 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 23585851 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 24477688 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 19776007 | ||
| Pubmed | A unique role for galectin-9 in angiogenesis and inflammatory arthritis. | 3.74e-09 | 3 | 55 | 3 | 29433546 | |
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 26582205 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 37105392 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 9153289 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 33316546 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 18974023 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 9038233 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 23144904 | ||
| Pubmed | Impaired Gal-9 Dysregulates the PBMC-Induced Th1/Th2 Imbalance in Abortion-Prone Matings. | 3.74e-09 | 3 | 55 | 3 | 29651447 | |
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 36479526 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 28704475 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 21146220 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 23242525 | ||
| Pubmed | Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice. | 3.74e-09 | 3 | 55 | 3 | 19851072 | |
| Pubmed | The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes. | 3.74e-09 | 3 | 55 | 3 | 33923930 | |
| Pubmed | Alarmin function of galectin-9 in murine respiratory tularemia. | 3.74e-09 | 3 | 55 | 3 | 25898318 | |
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 31937306 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 21426359 | ||
| Pubmed | Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases. | 3.74e-09 | 3 | 55 | 3 | 31969388 | |
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 23836896 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 18282810 | ||
| Pubmed | Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia. | 3.74e-09 | 3 | 55 | 3 | 35241678 | |
| Pubmed | Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes. | 3.74e-09 | 3 | 55 | 3 | 7890611 | |
| Pubmed | Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner. | 3.74e-09 | 3 | 55 | 3 | 22341088 | |
| Pubmed | Regulation of M1‑type and M2‑type macrophage polarization in RAW264.7 cells by Galectin‑9. | 3.74e-09 | 3 | 55 | 3 | 28990062 | |
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 32380082 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 24083426 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 23667648 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 37279535 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 18579572 | ||
| Pubmed | The protective function of galectin-9 in liver ischemia and reperfusion injury in mice. | 3.74e-09 | 3 | 55 | 3 | 25931247 | |
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 22627368 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 28877989 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 33153471 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 19800850 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 22052881 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 17560833 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 38987795 | ||
| Pubmed | 3.74e-09 | 3 | 55 | 3 | 35643073 | ||
| Pubmed | Galectin-9 functionally impairs natural killer cells in humans and mice. | 3.74e-09 | 3 | 55 | 3 | 23408620 | |
| Pubmed | Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. | 1.50e-08 | 4 | 55 | 3 | 20463811 | |
| Pubmed | 1.50e-08 | 4 | 55 | 3 | 38686388 | ||
| Pubmed | 1.50e-08 | 4 | 55 | 3 | 22677125 | ||
| Pubmed | 1.50e-08 | 4 | 55 | 3 | 32855403 | ||
| Pubmed | Galectin-3 mediates oligomerization of secreted hensin using its carbohydrate-recognition domain. | 1.50e-08 | 4 | 55 | 3 | 23657851 | |
| Pubmed | 1.50e-08 | 4 | 55 | 3 | 19234217 | ||
| Pubmed | 1.50e-08 | 4 | 55 | 3 | 18826117 | ||
| Pubmed | 1.50e-08 | 4 | 55 | 3 | 24333756 | ||
| Pubmed | 1.50e-08 | 4 | 55 | 3 | 38853593 | ||
| Pubmed | 1.50e-08 | 4 | 55 | 3 | 35715604 | ||
| Pubmed | Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies. | 1.50e-08 | 4 | 55 | 3 | 24958847 | |
| Pubmed | 1.50e-08 | 4 | 55 | 3 | 19017954 | ||
| Pubmed | 1.50e-08 | 4 | 55 | 3 | 30120235 | ||
| Pubmed | Galectin-9 Targets NLRP3 for Autophagic Degradation to Limit Inflammation. | 1.50e-08 | 4 | 55 | 3 | 33963043 | |
| Pubmed | Galectin-9: A novel promoter of atherosclerosis progression. | 1.50e-08 | 4 | 55 | 3 | 36459823 | |
| Pubmed | [Expression of Galectin-9 and Tim-3 in lungs of mice with asthma]. | 1.50e-08 | 4 | 55 | 3 | 21575348 | |
| Pubmed | Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts. | 1.50e-08 | 4 | 55 | 3 | 18346632 | |
| Pubmed | 1.50e-08 | 4 | 55 | 3 | 11839756 | ||
| Pubmed | 1.50e-08 | 4 | 55 | 3 | 33107565 | ||
| Pubmed | 1.50e-08 | 4 | 55 | 3 | 19670381 | ||
| Pubmed | Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models. | 1.50e-08 | 4 | 55 | 3 | 29611821 | |
| Pubmed | 1.50e-08 | 4 | 55 | 3 | 30763585 | ||
| Pubmed | 1.50e-08 | 4 | 55 | 3 | 25450716 | ||
| Pubmed | The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. | 1.50e-08 | 4 | 55 | 3 | 16286920 | |
| Pubmed | Galectin-9 regulates the threshold of B cell activation and autoimmunity. | 1.50e-08 | 4 | 55 | 3 | 34369876 | |
| Pubmed | Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2. | 1.50e-08 | 4 | 55 | 3 | 33727589 | |
| Pubmed | Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells. | 1.50e-08 | 4 | 55 | 3 | 19362679 | |
| Pubmed | 1.50e-08 | 4 | 55 | 3 | 33203936 | ||
| Pubmed | 1.50e-08 | 4 | 55 | 3 | 25578313 | ||
| Pubmed | 1.50e-08 | 4 | 55 | 3 | 29844236 | ||
| Pubmed | Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency. | 1.50e-08 | 4 | 55 | 3 | 22021615 | |
| Pubmed | Embryonic implantation in galectin 1/galectin 3 double mutant mice. | 3.73e-08 | 5 | 55 | 3 | 9566950 | |
| Pubmed | 3.73e-08 | 5 | 55 | 3 | 29242193 | ||
| Pubmed | 3.73e-08 | 5 | 55 | 3 | 28951537 | ||
| Pubmed | 3.73e-08 | 5 | 55 | 3 | 26278059 | ||
| Pubmed | Galectin-9 mediates neutrophil capture and adhesion in a CD44 and β2 integrin-dependent manner. | 3.73e-08 | 5 | 55 | 3 | 34847625 | |
| Pubmed | 3.73e-08 | 5 | 55 | 3 | 22469568 | ||
| Pubmed | 3.73e-08 | 5 | 55 | 3 | 37352334 | ||
| Pubmed | 3.73e-08 | 5 | 55 | 3 | 33664349 | ||
| Pubmed | The glucose transporter 2 regulates CD8+ T cell function via environment sensing. | 3.73e-08 | 5 | 55 | 3 | 37884694 | |
| Pubmed | 3.73e-08 | 5 | 55 | 3 | 25158758 | ||
| Pubmed | 3.73e-08 | 5 | 55 | 3 | 21385853 | ||
| Pubmed | C/EBPzeta (CHOP/Gadd153) is a negative regulator of LPS-induced IL-6 expression in B cells. | 3.73e-08 | 5 | 55 | 3 | 19782405 | |
| Pubmed | Tim3 binding to galectin-9 stimulates antimicrobial immunity. | 7.46e-08 | 6 | 55 | 3 | 20937702 | |
| Pubmed | 7.46e-08 | 6 | 55 | 3 | 8674632 | ||
| Pubmed | 7.46e-08 | 6 | 55 | 3 | 28394331 | ||
| Pubmed | 7.46e-08 | 6 | 55 | 3 | 23296703 | ||
| Pubmed | Role of galectin-1 in the developing mouse olfactory system. | 1.30e-07 | 7 | 55 | 3 | 8873770 | |
| Pubmed | 2.08e-07 | 8 | 55 | 3 | 31661141 | ||
| Pubmed | 2.08e-07 | 8 | 55 | 3 | 23751344 | ||
| Pubmed | 2.08e-07 | 8 | 55 | 3 | 36883358 | ||
| Pubmed | 3.12e-07 | 9 | 55 | 3 | 21670307 | ||
| Pubmed | Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells. | 3.12e-07 | 9 | 55 | 3 | 25065622 | |
| Pubmed | 4.46e-07 | 10 | 55 | 3 | 20950796 | ||
| GeneFamily | Galectins | 3.83e-06 | 15 | 38 | 3 | 629 | |
| GeneFamily | Bone morphogenetic proteins|Astacins | 2.34e-04 | 11 | 38 | 2 | 455 | |
| GeneFamily | Forkhead boxes | 3.68e-03 | 43 | 38 | 2 | 508 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 4.82e-03 | 163 | 38 | 3 | 590 | |
| Coexpression | NABA_MATRISOME | LGALS9C ADAMTS10 BMP8B LGALS9B WNT6 NCAN HAPLN4 HAPLN2 BMP8A IL17D SSPOP LGALS9 | 9.34e-07 | 1008 | 55 | 12 | MM17056 |
| Coexpression | NABA_MATRISOME | LGALS9C ADAMTS10 BMP8B LGALS9B WNT6 NCAN HAPLN4 HAPLN2 BMP8A IL17D SSPOP LGALS9 | 1.12e-06 | 1026 | 55 | 12 | M5889 |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3 | 9.49e-06 | 357 | 55 | 7 | MM828 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 1.39e-05 | 146 | 55 | 5 | MM973 | |
| Coexpression | NABA_PROTEOGLYCANS | 5.46e-05 | 35 | 55 | 3 | M5882 | |
| Coexpression | NABA_PROTEOGLYCANS | 5.94e-05 | 36 | 55 | 3 | MM17061 | |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_UP | 6.28e-05 | 200 | 55 | 5 | M8112 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3 | 9.07e-05 | 350 | 55 | 6 | M1949 | |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 9.23e-05 | 217 | 55 | 5 | MM861 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3 | 1.20e-04 | 8 | 55 | 2 | M10331 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 1.44e-04 | 738 | 55 | 8 | MM17058 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3 | 1.54e-04 | 9 | 55 | 2 | MM608 | |
| Coexpression | GSE13887_ACT_CD4_VS_NO_TREATED_CD4_TCELL_UP | 1.57e-04 | 129 | 55 | 4 | M481 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 1.62e-04 | 751 | 55 | 8 | M5885 | |
| Coexpression | MIKKELSEN_MEF_LCP_WITH_H3K4ME3 | 2.27e-04 | 142 | 55 | 4 | MM840 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.29e-06 | 153 | 55 | 5 | e7d20c88466ff81db613869cf7a6a4bb95fd6c2f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 4.79e-06 | 200 | 55 | 5 | be1abe5bb1ce4e7dfec63af4ed0fc5b96bf77866 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.19e-05 | 146 | 55 | 4 | cffa91d76606f74553d81150adbb23b003746316 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.55e-05 | 150 | 55 | 4 | fdbfc8f743cf848978cf0488493f6df60be53982 | |
| ToppCell | 3'_v3-blood-Lymphocytic_Invariant-Inducer-like-ILC3|blood / Manually curated celltypes from each tissue | 4.24e-05 | 157 | 55 | 4 | eb2520c237543ea4869d4386afc0457b111f6193 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-05 | 165 | 55 | 4 | ab6ed7e30096c418e7be2d5eec33feeddd1387d9 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.39e-05 | 167 | 55 | 4 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.39e-05 | 167 | 55 | 4 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-05 | 175 | 55 | 4 | 1d1cdbf3221b03e24eae38afd57cbd6736b37a53 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-05 | 175 | 55 | 4 | d67c77eee979ad029e7545f383326f0ff77c6e5f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-05 | 176 | 55 | 4 | ef0ff02897104e938c8a632357d8f1a6f014e68a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-05 | 176 | 55 | 4 | da0983929fa682a68e536c298a2d7add188b7563 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Activated_fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.05e-05 | 179 | 55 | 4 | 5787ffba96918db80256ced076a455a84ba01384 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.21e-05 | 180 | 55 | 4 | da723df348d7b8449bb1124f23fe6fa706412adb | |
| ToppCell | droplet-Heart-nan-3m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.21e-05 | 180 | 55 | 4 | 5b146a94708b3c3610542a4d0925f3f7a2b19185 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.21e-05 | 180 | 55 | 4 | 50758b1e7be2e43f83c10ab106900c067e61f5f7 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.52e-05 | 182 | 55 | 4 | e98ca9df33a1a81fc83ecf73d5141a14f2bc985c | |
| ToppCell | 15-Trachea-Epithelial-Multiciliated_precursor|Trachea / Age, Tissue, Lineage and Cell class | 8.01e-05 | 185 | 55 | 4 | 9a8b8360d99375b726ca8e3c9a3f9b08919892d7 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.35e-05 | 187 | 55 | 4 | b8f88599e22b9b345c7ec3bbecd87a8b2a033f9f | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 9.43e-05 | 193 | 55 | 4 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | distal-1-Hematologic-EREG+_Dendritic|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.06e-04 | 199 | 55 | 4 | 15249f2f48b1e99d9d062835fd4c705a159e4abb | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-04 | 199 | 55 | 4 | fbec5c034576cb1adaf05f6f97cc5525d19e0c1b | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-04 | 199 | 55 | 4 | a13f4b8a039304e685464cc8879659824cad5a3e | |
| ToppCell | distal-Hematologic-EREG+_Dendritic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.08e-04 | 200 | 55 | 4 | 7809c74a2e52768854b66a135522138281bc4449 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial-Glia_progenitor_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.08e-04 | 200 | 55 | 4 | 4b937b1d0179d1d0e51931f35720e205d460a07e | |
| Disease | fish oil supplement exposure measurement, triglyceride measurement | 1.36e-04 | 10 | 52 | 2 | EFO_0004530, EFO_0600007 | |
| Disease | monocyte count | THEM4 ARHGAP23 TMEM121B SLC22A3 NFKBIE NEURL1B NYAP1 BBC3 FOSL1 | 4.52e-04 | 1320 | 52 | 9 | EFO_0005091 |
| Disease | diabetes mellitus (implicated_via_orthology) | 9.64e-04 | 26 | 52 | 2 | DOID:9351 (implicated_via_orthology) | |
| Disease | C-reactive protein measurement | 1.16e-03 | 1206 | 52 | 8 | EFO_0004458 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.51e-03 | 42 | 52 | 2 | EFO_0008317, EFO_0008596, EFO_0020945 | |
| Disease | sexual dimorphism measurement | 3.13e-03 | 1106 | 52 | 7 | EFO_0021796 | |
| Disease | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | 3.38e-03 | 170 | 52 | 3 | EFO_0000685, EFO_0007791, EFO_0007837 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 3.96e-03 | 53 | 52 | 2 | C4707243 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| APRPAARPCRGRSAP | 171 | P0DSO1 | |
| PPPNRCGRLVLGPRL | 21 | B3EWF7 | |
| PRLGAPAVPRRGPRS | 126 | P59051 | |
| PSGPQPRRGCPRRPR | 331 | P46092 | |
| APPRGPRLTRFPACG | 41 | O95076 | |
| ARPGCRPRRPHPAAR | 76 | Q96PG8 | |
| RRRRPPCAPGPDSGP | 181 | Q9HA90 | |
| FSPPPPRRQRRGTGA | 56 | Q9H324 | |
| PPRATARLPQRGCPG | 936 | Q07912 | |
| GVPARPGRRAERPPQ | 21 | Q8N7S6 | |
| RERPCPARGAPARPS | 151 | A6NK89 | |
| TPRPRCGGLPDPGVR | 306 | Q9GZV7 | |
| GPDPRARPGIACLRP | 71 | Q9UJH8 | |
| QPVCFPPRPRGRRQK | 166 | Q6DKI2 | |
| SPGRRPPRAGRPLCQ | 96 | O00221 | |
| QPVCFPPRPRGRRQK | 166 | Q3B8N2 | |
| QPVCFPPRPRGRRQK | 166 | O00182 | |
| CRTPRPPLRPGAVGH | 236 | Q8N3J3 | |
| CPAGGRPADRRFRPP | 71 | Q8TAD2 | |
| CEPSTPRRSRGRPPG | 211 | Q9UMN6 | |
| GRPPGRPAGPCRRKQ | 221 | Q9UMN6 | |
| GCPRGPRLLRIAPRP | 676 | A6NGR9 | |
| RLQPRGDGPRQPGPR | 336 | Q8WWR8 | |
| GLRRVCPRPRGATAP | 336 | Q12950 | |
| PFGRAGLQGRRPPVC | 1076 | Q08828 | |
| PPRPVARRAGGPLAR | 631 | Q5SW24 | |
| CIQPQPTAGPRPRGR | 131 | Q8IU54 | |
| RPPPGCPQRRLGARE | 26 | Q7Z5Y6 | |
| QRRQPPGHRPAPRGG | 536 | Q96RR4 | |
| PIVNPRARCGGRRPG | 331 | Q86UW8 | |
| RPPPGCPQRRLGARE | 26 | P34820 | |
| PASRGPEPPERRGRC | 76 | O75751 | |
| APGCPRPPQDALARR | 161 | Q8NCU7 | |
| LGPPPGVRRRPCEQI | 86 | P15407 | |
| GRPMGPPRRRCLPAA | 456 | Q9BZF2 | |
| PPRRRCLPAASGPGA | 461 | Q9BZF2 | |
| RRGPEPRKSGTPPCR | 816 | Q6ZVC0 | |
| TPEPGCCAPRGRPRR | 91 | Q5JXM2 | |
| RLQAPGPAGRPRCFP | 56 | Q9H611 | |
| GPAGRPRCFPLRAAR | 61 | Q9H611 | |
| RRCARPPCPGPARQS | 3671 | A2VEC9 | |
| PGRRGRRRGCAPSPR | 181 | Q9BXQ6 | |
| GLPPLDCPRGAPIRR | 261 | Q8IYG6 | |
| PGSPRPRRRRLEPNC | 146 | Q9UD57 | |
| PRRRCGGPAPGVRTV | 321 | O14594 | |
| ATRPAPGPGRRARCP | 31 | Q9NV39 | |
| PGPGRRARCPQSAHP | 36 | Q9NV39 | |
| AAPTPAPGPGRRRRR | 51 | Q13461 | |
| AQCARPGPARQPRPR | 351 | A0A0B4J2F2 | |
| AQCARPGPARQPRPR | 351 | P57059 | |
| QRGGSRPSPGPIRCR | 51 | Q8N365 | |
| APVGCPKGARRRRPI | 11 | Q96N96 | |
| GAPPRRQRVPGRACP | 41 | P49842 | |
| CLPPVGRRLPGSEPR | 16 | Q5T1C6 | |
| QLPLGPRDGCSPRRP | 21 | Q9P227 | |
| RPGAGQPPRRKECTP | 26 | Q9UHP9 | |
| VVPRGPRGGRPFQCA | 281 | Q8NBB4 | |
| AAAIPCGPRERPRPA | 256 | A8MQ27 | |
| QCGCQAPRGRAPPRP | 131 | Q9Y6F9 | |
| PRPGDRGCPARGRPK | 911 | Q96JG9 | |
| GTNKPPRCRGRGARP | 391 | Q8N5A5 | |
| PAQPPRRRTGTRACP | 106 | Q6UXQ8 | |
| AGPLPRRRARCGCPR | 1216 | O15399 |